statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors PR Newswire...

Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory...

FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal Cancer to Be Held on May 23

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024...

Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024

Guardant Health (NASDAQ:GH - Get Free Report)s stock had its "neutral" rating reissued by investment analysts at Guggenheim in a note issued to investors on Friday, Benzinga reports. GH has...

Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)

This is a signal that GH's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Guardant Health (GH, $20.25) Stochastic Oscillator left the overbought zone on April 01, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

Guardant Health (GH, $20.25) price exceeded its 50-day Moving Average on April 01, 2024

Investors in Guardant Health Inc (GH) saw new options become available this week, for the June 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay...

First Week of GH June 21st Options Trading

Portman Square Capital LLP decreased its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 77.0% in the 4th quarter, according to the company in its most recent filing with the...

Guardant Health, Inc. (NASDAQ:GH) Holdings Reduced by Portman Square Capital LLP

In this article, we will be taking a look at the 2o foods to reduce cancer risk. If you do no want learn about the global and US cancer stats, head straight to the 5 Foods To Reduce Cancer...

20 Foods To Reduce Cancer Risk

Guardant Health, Inc. (NASDAQ:GH - Get Free Report) shares rose 3.9% during trading on Thursday . The stock traded as high as $18.82 and last traded at $18.66. Approximately 453,331 shares were...

Guardant Health (NASDAQ:GH) Trading Up 3.9%

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Volume	954,659.00
52-Wk High	$41.06
52-Wk Low	$15.81

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.87	--	--	N/A
Q4'23	-$0.86	-$1.58	-83.27%	MISSED
Q3'23	-$0.97	-$0.73	24.55%	BEAT
Q2'23	-$1.22	-$0.67	44.95%	BEAT
Q1'23	-$1.29	-$1.30	-0.42%	MISSED

GH Guardant Health Inc

About

Feed

News

Sentiment

Earnings

Fundamentals